Usefulness of biomarker strategy to improve GRACE score’s prediction performance in patients with non-ST-segment elevation acute coronary syndrome and low event rates.

Usefulness of biomarker strategy to improve GRACE score's prediction performance in patients with non-ST-segment elevation acute coronary syndrome and low event rates. Publié dans American Journal of Cardiology, le 01 septembre 2010. En savoir plus en consultant le site. Auteurs : Beygui F, Silvain J, Pena A, Bellemain-Appaix A, Collet JP, Drexler H, Bhatt D, Vicaut E,…

Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial.

Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial. Publié dans American Heart Journal, le 01 janvier 2010. En savoir plus en consultant le site. Auteurs : White HD, Aylward PE, Gallo R, Bode…

Effect of irbesartan and enalapril in non-ST elevation acute coronary syndrome: results of the randomized, double-blind ARCHIPELAGO study.

Effect of irbesartan and enalapril in non-ST elevation acute coronary syndrome: results of the randomized, double-blind ARCHIPELAGO study. Publié dans European Heart Journal, le 01 novembre 2009. En savoir plus en consultant le site. Auteurs : Montalescot G, Drexler H, Gallo R, Pearson T, Thoenes M, Bhatt DL. Abstract AIMS: This study investigated the effects of irbesartan…